Coverage / GHRS / Trade Card

GHRS

GH Research PLC

OPPORTUNISTIC BUY 2026-08-01 Updated today USD 28.07 Healthcare - BiotechnologyAWAIT ENTRY
53

Position levels

Currenttoday
USD 28.07
Buy <=wait / entry
USD 18.00
Trim >=take some off
USD 30.00
Thesis breakA formal rejection or non-acceptance of the GH001 IND complete response by the U...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case18%100 / 10018.0
Base case52%62 / 10032.2
Bear case30%10 / 1003.0
Weighted conviction53 / 100 - OPPORTUNISTIC BUY

Top risks

  • Publication of full Phase 2a postpartum depression trial results (Jun 2026)
  • Phase 2b TRD results published in JAMA Psychiatry with Phase 3 program doses selected
  • Multiple analyst Buy ratings with average price target of $30.11
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.